Lubabegron Formulations for Bovine Emission Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing ammonia and carbon dioxide emissions from bovines are costly, inconvenient, and of limited effectiveness, and existing solutions do not address the need for alternatives that do not negatively impact bovine muscle accumulation or meat quality.
Innovation Solution
Oral administration of lubabegron or its physiologically acceptable salts to bovines, either through feed additives or direct administration, to reduce ammonia and carbon dioxide emissions, with lubabegron being formulated into animal feeds or administered via drinking water to promote efficient emission reduction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-generated harmful factors
If dietary manipulation strategies are used to reduce ammonia and carbon dioxide emissions, then emission levels decrease, but bovine muscle accumulation and meat quality are negatively affected
Solution Approach 1:
The patent introduces lubabegron as an intermediary substance (beta-3 adrenergic receptor agonist) that mediates between emission reduction goals and muscle maintenance requirements. This pharmacological agent selectively targets fat metabolism without interfering with protein synthesis pathways, thereby reducing emissions while preserving muscle accumulation capacity
Solution Approach 2:
The patent changes the physiological parameters of bovine metabolism by administering lubabegron, which selectively activates beta-3 adrenergic receptors to increase lipolysis and fat oxidation. This parameter change allows the animal to emit fewer ammonia and carbon dioxide gases while maintaining normal protein metabolism and muscle growth rates
2Object-generated harmful factors
If filtration and barrier methods are used to control ammonia emissions, then emission levels decrease, but operational convenience and cost-effectiveness worsen
Solution Approach 1:
The patent employs lubabegron to enable the bovine system to self-regulate ammonia emissions through pharmacological modulation of digestive and metabolic processes. The treated animal naturally reduces emissions without requiring external filtration infrastructure or barrier installations, thereby maintaining operational convenience while achieving emission control
Solution Approach 2:
The patent replaces mechanical emission control systems (filtration equipment, physical barriers) with a biochemical approach using lubabegron administration. This substitution eliminates the need for complex mechanical infrastructure, simplifying operations and reducing maintenance requirements while effectively controlling ammonia emissions
Data Source
AI summary
The present disclosure provides methods and formulations for reducing ammonia and carbon dioxide emissions from a bovine using lubabegron, or a physiologically acceptable salt thereof. The present disclosure also provides bovine feed additives and bovine feed compositions.